logo
15:58 Jan 28

Lupin Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
2129.50
-21.00 (-0.98%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Lupin Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
2129.50
-21.00 (-0.98%)
15:58 Jan 28
Quality
image/svg+xml

68/100
High Financial Strength

Valuation
image/svg+xml

42/100
Mid Valuation

Technical

59/100
Technically Neutral

Strength

15

Weakness

2

Opportunity

1

Threats

1

19.07 %

ROE %

11.23 %

ROA %

94.67

EPS

376.77

BVPS

14.45 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
15162.96 16405.48 16641.66 20010.82 22707.9
Operating Expenses +
12596.08 16118.26 14843.54 16200.3 17424.59
Raw Material
5847.1 6679.56 6626.03 7100.91 7100.03
Increase Decrease in Cost
-484.86 -198.32 153.73 -457.44 -257.78
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
2825.9 2989.3 3087.15 3494.57 3964.2
Miscellaneous Expenses
9762.56 13535.42 10853.07 11979.7 11903.38
Operating Profit
2566.88 287.22 1798.12 3810.52 5283.31
Other Income
136.29 141.69 73.36 120.17 195.82
Depreciation
887.41 1658.71 880.69 1196.81 1169.26
Interest
140.64 142.77 274.3 311.61 294.87
Profit before tax and exceptio..
1675.12 -1372.57 716.49 2422.27 4015
Exceptional Items
0 0 0 0 0
PBT
1675.12 -1372.57 716.49 2422.27 4015
Provision for Taxation
448.52 137.15 268.8 486.7 708.74
Net Profit
1226.6 -1509.72 447.69 1935.57 3306.26
NET Profit after MI
1216.53 -1528.04 430.08 1914.48 3281.62
EPS
26.72 -33.65 9.41 41.87 71.95
Operating Profit Margin (%)
16.93 1.75 10.8 19.04 23.27
Net Profit Margin (%)
8.02 -9.31 2.58 9.57 14.45

Lupin Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 46.90 46.90 46.90 46.90 47.00 47.00
FII 21.50 20.50 21.20 21.50 22.00 21.50
Public 25.60 26.60 25.60 25.40 24.80 25.10
Others 6.00 6.00 6.30 6.20 6.20 6.40
Shareholder Shares Holding %
Research 360 logo
Download Our App On: